Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma


Autoria(s): Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph
Data(s)

2012

Resumo

Current treatment guidelines generally suggest using lower and weight-adjusted glucocorticoid replacement doses in patients with insufficiency of the hypothalamic-pituitary-adrenal (HPA) axis. Although data in patients with acromegaly revealed a positive association between glucocorticoid dose and mortality, no comparable results exist in patients with nonfunctioning pituitary adenomas (NFPA).

Formato

application/pdf

Identificador

http://boris.unibe.ch/9375/1/Zueger%20JClinEndocrinolMetab%202012.pdf

Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. Journal of clinical endocrinology and metabolism, 97(10), E1938-42. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2012-2432 <http://dx.doi.org/10.1210/jc.2012-2432>

doi:10.7892/boris.9375

info:doi:10.1210/jc.2012-2432

info:pmid:22872686

urn:issn:0021-972X

Idioma(s)

eng

Publicador

Endocrine Society

Relação

http://boris.unibe.ch/9375/

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Zueger, Thomas; Kirchner, Paul; Herren, Coline; Fischli, Stefan; Zwahlen, Marcel; Christ, Emanuel; Stettler, Christoph (2012). Glucocorticoid Replacement and Mortality in Patients with Nonfunctioning Pituitary Adenoma. Journal of clinical endocrinology and metabolism, 97(10), E1938-42. Chevy Chase, Md.: Endocrine Society 10.1210/jc.2012-2432 <http://dx.doi.org/10.1210/jc.2012-2432>

Palavras-Chave #610 Medicine & health
Tipo

info:eu-repo/semantics/article

info:eu-repo/semantics/publishedVersion

NonPeerReviewed